JBC Avanti Polar Lipids

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M407536200 on December 13, 2004 Originally published In Press as doi:10.1074/jbc.M407536200 on November 29, 2004 Originally published In Press as doi:10.1074/jbc.M407536200 on November 16, 2004

J. Biol. Chem., Vol. 280, Issue 5, 3275-3285, February 4, 2005
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
280/5/3275    most recent
M407536200v3
M407536200v2
M407536200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Casarosa, P.
Right arrow Articles by Leurs, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Casarosa, P.
Right arrow Articles by Leurs, R.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

CC and CX3C Chemokines Differentially Interact with the N Terminus of the Human Cytomegalovirus-encoded US28 Receptor*

Paola Casarosa{ddagger}§§, Maria Waldhoer§, Patricia J. LiWang¶, Henry F. Vischer{ddagger}¶¶, Thomas Kledal||, Henk Timmerman{ddagger}, Thue W. Schwartz**, Martine J. Smit{ddagger}||||, and Rob Leurs{ddagger}{ddagger}{ddagger}

From the {ddagger}Leiden/Amsterdam Center for Drug Research, Division of Medicinal Chemistry, Faculty of Chemistry, De Boelelaan 1083, 1081 HV Amsterdam, The Netherlands, §Ernest Gallo Research Center, University of California, San Francisco, California 94608, the Department of Biochemistry and Biophysics, Texas A&M University, Texas 77843, ||Copenhagen University Hospital, Hvidovre 2650, Denmark, **Laboratory for Molecular Pharmacology, Panum Institute, University of Copenhagen, Copenhagen DK-2100, Denmark, and 7TM-Pharma A/, Fremtidsvej 3, Hørsholm DK-2970, Denmark

Human cytomegalovirus (HCMV) is the causative agent of life-threatening systemic diseases in immunocompromised patients as well as a risk factor for vascular pathologies, like atherosclerosis, in immunocompetent individuals. HCMV encodes a G-protein-coupled receptor (GPCR), referred to as US28, that displays homology to the human chemokine receptor CCR1 and binds several chemokines of the CC family as well as the CX3C chemokine fractalkine with high affinity. Most importantly, following HCMV infection, US28 activates several intracellular pathways, either constitutively or in a chemokine-dependent manner. In this study, our goal was to understand the molecular interactions between chemokines and the HCMV-encoded US28 receptor. To achieve this goal, a double approach has been used, consisting in the analysis of both receptor and ligand mutants. This approach has led us to identify several amino acids located in the N terminus of US28 that differentially contribute to the high affinity binding of CC versus CX3C chemokines. Additionally, our results highlight the importance of secondary modifications occurring at US28, such as sulfation, for ligand recognition. Finally, the effects of chemokine dimerization and interaction with glycosaminoglycans (GAGs) on chemokine binding and activation of US28 were investigated as well using CCL4 as model ligand. In line with the two-state model describing chemokine/receptor interaction, we show that an aromatic residue in the N-loop region of CCL4 promotes tight binding to US28, whereas receptor activation depends on the presence of the N terminus of CCL4, as shown previously for CCR5.


Received for publication, July 6, 2004 , and in revised form, November 8, 2004.

* The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§§ Supported by Altana Nederland B. V. (Zwanenburg, The Netherlands).

¶¶ Supported by the Technology Foundation (STW).

|||| Supported by the Royal Netherlands Academy of Arts and Sciences.

{ddagger}{ddagger} To whom correspondence should be addressed: Leiden/Amsterdam Center for Drug Research, Division of Medicinal Chemistry, Faculty of Chemistry, De Boelelaan 1083, 1081 HV Amsterdam, The Netherlands. Tel.: 31-20-4447579; Fax: 31-20-4447610; E-mail: leurs{at}few.vu.nl.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Am. J. Respir. Cell Mol. Bio.Home page
J. Liu, S. Louie, W. Hsu, K. M. Yu, H. B. Nicholas Jr., and G. L. Rosenquist
Tyrosine Sulfation Is Prevalent in Human Chemokine Receptors Important in Lung Disease
Am. J. Respir. Cell Mol. Biol., June 1, 2008; 38(6): 738 - 743.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
M. P. M. Stropes and W. E. Miller
Functional analysis of human cytomegalovirus pUS28 mutants in infected cells
J. Gen. Virol., January 1, 2008; 89(1): 97 - 105.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
J. Loeffler, M. Steffens, E.-M. Arlt, M.-R. Toliat, M. Mezger, A. Suk, T. F. Wienker, H. Hebart, P. Nurnberg, M. Boeckh, et al.
Polymorphisms in the genes encoding chemokine receptor 5, interleukin-10, and monocyte chemoattractant protein 1 contribute to cytomegalovirus reactivation and disease after allogeneic stem cell transplantation.
J. Clin. Microbiol., May 1, 2006; 44(5): 1847 - 1850.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
P. Najarro, C. Gubser, M. Hollinshead, J. Fox, J. Pease, and G. L. Smith
Yaba-like disease virus chemokine receptor 7L, a CCR8 orthologue.
J. Gen. Virol., April 1, 2006; 87(Pt 4): 809 - 816.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.